IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 277 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $337 | -99.8% | 9,422 | +72.1% | 0.03% | +10.0% |
| Q2 2022 | $203,000 | -50.1% | 5,475 | -59.0% | 0.03% | -41.2% |
| Q4 2021 | $407,000 | -45.9% | 13,368 | -15.6% | 0.05% | -59.2% |
| Q3 2020 | $752,000 | +97.9% | 15,842 | +151.9% | 0.12% | +184.1% |
| Q4 2019 | $380,000 | -70.0% | 6,288 | -68.1% | 0.04% | -69.0% |
| Q2 2019 | $1,265,000 | +3.2% | 19,690 | +30.4% | 0.14% | +14.5% |
| Q1 2019 | $1,226,000 | +26.7% | 15,100 | -15.6% | 0.12% | +10.7% |
| Q4 2018 | $968,000 | -27.9% | 17,900 | -44.4% | 0.11% | +67.2% |
| Q2 2018 | $1,342,000 | -44.8% | 32,200 | -41.7% | 0.07% | -48.1% |
| Q1 2018 | $2,433,000 | +0.6% | 55,200 | +14.8% | 0.13% | -12.2% |
| Q4 2017 | $2,419,000 | +99.8% | 48,093 | +101.3% | 0.15% | +77.1% |
| Q3 2017 | $1,211,000 | +10.5% | 23,893 | +10.9% | 0.08% | +15.3% |
| Q2 2017 | $1,096,000 | +105.6% | 21,545 | +93.4% | 0.07% | +125.0% |
| Q4 2016 | $533,000 | – | 11,141 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |